CHAMPIONS ONCOLOGY, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.83 USD | -2.62% |
|
-5.85% | -14.06% |
| 15/03 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
| 13/03 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 67.43M | - | - | - | - | ||
| 47.02B | - | |||||
| 41.86B | ||||||
| 41.76B | ||||||
| 28.8B | ||||||
| 26.05B |
